AYTUZ Projected Dividend Yield
Aytu BioScience Inc ( OTCBB : AYTUZ )Aytu Bioscience is a pharmaceutical company focused on commercializing products that address healthcare needs. Co.'s Primary Care Portfolio includes: Natesto®, which is a nasal formulation of testosterone for men with hypogonadism (low testosterone); ZolpiMist®, which is an oral spray prescription sleep aid; and Tuzistra® XR, which is a codeine-based antitussive syrup. Co.'s Pediatric Portfolio includes; Cefaclor, which is a cephalosporin antibiotic suspension; Karbinal® ER, which is an extended-release carbinoxamine (antihistamine) suspension indicated to treat various allergic conditions; and Poly-Vi-Flor® and Tri-Vi-Flor®, which are prescription fluoride-based supplement product lines. 20 YEAR PERFORMANCE RESULTS |
AYTUZ Dividend History Detail AYTUZ Dividend News AYTUZ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |